Evidence map›Paper›PMID 25667681›Full record

ArticleExperimental and therapeutic medicine2015

Expression of porcine protegrin-1 in

Mingfu Niu, Shumao Chai, Xiaoyan You, Wenhui Wang, Cuili Qin, Qiang Gong, Tingting Zhang, Peng Wan

Erratum issuedOpen access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. A eukaryotic expression strategy for producing the novel antimicrobial peptide PRW4.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2020
    Article
  6. Antifungal Peptides as Therapeutic Agents.Frontiers in cellular and infection microbiology · 2020
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mingfu NiuFood and Bioengineering College, Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
Shumao ChaiFood and Bioengineering College, Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
Xiaoyan YouFood and Bioengineering College, Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
Wenhui WangFood and Bioengineering College, Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
Cuili QinFood and Bioengineering College, Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
Qiang GongFood and Bioengineering College, Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
Tingting ZhangFood and Bioengineering College, Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
Peng WanFood and Bioengineering College, Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
Henan University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protegrin-1 (PG-1), a β-hairpin antimicrobial peptide (AMP), is amongst the shortest AMPs in sequence length while remaining active against a variety of microorganisms. The aim of this study was produce recombinant PG-1 and investigate its anticancer activity. A DNA sequence encoding the mature PG-1, fused with a 6His-tag, was cloned into the pPICZα-A vector and transformed into

Indexed as

antibacterial peptide protegrin-1/Hisanticancer activityexpression and purification

Identifiers

PMID25667681
PMCPMC4316971
OpenAlexW2023064614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.